Renaissance Capital logo

DBV Technologies Priced, Nasdaq: DBVT

French biotech developing immunotherapy patches that treat food allergies.

Industry: Health Care

First Day Return: +5.8%

French biotech developing immunotherapy patches that treat food allergies.

DBV Technologies (DBVT) Performance

Created with Highcharts 10.3.2Chart context menuDBVT vs. IPO Index (IPOUSA)20152016201720182019202020212022202320242025-100%0%+ 100%+ 200%+ 300%View 5 days5dView 1 month1mView 3 months3mView year to dateYTDView 1 year1yView allAllRenaissance IPO IndexOur ETF tracks the IPO Index